Autobio(SH:603658) Xin Lang Cai Jing·2025-10-24 21:09Group 1 - The "Listing Company Hainan Tour" event, part of the "Enterprise Navigation" initiative, was launched on October 25 and will last for four days, focusing on key industries such as healthcare, finance, information technology, and electronic manufacturing [1][4]. - Hainan Free Trade Port is attracting more listed companies due to its unique policy advantages and industrial appeal, as highlighted by Yang Zengli, the Party Secretary of Antu Biotech [3][4]. - Antu Biotech, the first listed in vitro diagnostic R&D and manufacturing company in China, has taken its first step in investing in Hainan, aiming to leverage the Free Trade Port's policy advantages for building a "China R&D" hub [4]. Group 2 - Antu Biotech's product range includes immunology, microbiology, biochemistry, molecular diagnostics, and coagulation, with ongoing expansion into sequencing, mass spectrometry, and smart laboratory technologies [4]. - Yang Zengli emphasized the impressive open atmosphere and industrial clustering effect since the establishment of Hainan Free Trade Port, particularly noting the Boao Lecheng International Medical Tourism Pilot Zone's advantages in "licensed drug and device" usage and "zero tariff" policies [4]. - The company has invested in the first government investment fund focused on biomedicine in the Free Trade Port, planning to further develop R&D and industrialization projects, including establishing an innovative product pilot base and reagent manufacturing center [4]. Group 3 - Yang Zengli expressed optimism about the upcoming full closure operation of Hainan Island, which is expected to bring cross-border circulation and cost advantages, allowing the company to export in vitro diagnostic reagents as "Hainan-made" products to Southeast Asia [4]. - Antu Biotech aims to actively connect with local medical institutions and research platforms during the "Listing Company Hainan Tour" to explore specific cooperation paths, anticipating a dual interaction between policy and practice to accelerate local innovative technologies [4].